Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. (Q50089755)
Jump to navigation
Jump to search
scientific article published on 9 October 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. |
scientific article published on 9 October 2017 |
Statements
1 reference
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. (English)
1 reference
Jonathan M Ghergurovich
1 reference
Nello Mainolfi
1 reference
Vipin Suri
1 reference
Stephanie K Jeong
1 reference
Adam Friedman
1 reference
Mark G Manfredi
1 reference
Zemer Gitai
1 reference
Hahn Kim
1 reference
Joshua D Rabinowitz
1 reference
9 October 2017
1 reference
114
1 reference
43
1 reference
11404-11409
1 reference
Identifiers
1 reference
1 reference